$QCLS Income Statement | Understand Stock

$QCLS

$0.46 -$0.01 (2.33%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Administrative Expenses
Research and Development Expenses
Accretion of Debt Discount
Stock Based Compensation
Stock Option Modification Expenses
Warrant Issuance Expenses
Series F Warrant Issuance Expenses
Franchise Tax Expense
Series F-1 Warrant Issuance Expenses
Series G Warrant Issuance Expenses
Series H Warrant Issuance Expenses
Loss from Operations
Other (Income) Expenses
Interest and Dividend Income
(Gain)/Loss on Sales of Marketable Securities
Gain on Sales of Marketable Securities
Unrealized Gain on Marketable Securities
Gain on Debt Forgiveness
Impairment on Equity Investment
Change in fair value of Derivatives Liabilities
Change in fair value of Contingent Consideration
Change in fair value of warrant liability
Uninsured Casualty Losses
Loss on issuance of Series F-1 Convertible Preferred Stock
Loss on issuance of Series G Convertible Preferred Stock
Casualty Loss/(Gain)
Total Other (Income) Expenses

Loss Before Income Taxes
Net Loss
Basic and Dilutive net loss per common share
Weighted average basic and diluted common shares outstanding
Preferred Stock Dividends
Net Loss Attributable to Common Stockholders
Basic net loss per common share
Diluted net loss per common share
Weighted average basic common stock outstanding
Weighted average diluted common stock outstanding

Comments